Clinical Trial

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

Study acronym: FOCUS
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-19; most recent amendment 2026-02-16.
Status change: Not Yet Recruiting → Recruiting 2026-02-16
Trial Details
NCT Number NCT07195071
Lead Sponsor Columbia University
Collaborators: Natera, Inc.
Conditions Hereditary Cancer Syndrome
Enrollment 1,000 participants
Start Date 2026-02-12
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-18